Greece Pharmaceuticals and Healthcare Q3

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Lavipharm S.A. (LAVI) - Financial and Strategic SWOT Analysis Review

Lavipharm S.A. (LAVI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

Summary Lavipharm S.A (Lavipharm) is a an integrated company, which carries out developing, manufacturing, marketing and distribution of pharmaceutical, cosmetic, consumer health and over the counter (OTC) products. It provides various products for chronic pain, respiratory system, anti-inflammatory, ...

Industries: Drug and Medication | Countries: Greece, France, United States, Cyprus

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • July 2014
  • 116 pages

BMI View: Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic drug substitution; out-of-control hospital debt; extensive payment delays; drug shortages; and ...

Industries: Drug and Medication | Countries: Greece

MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 85 pages

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible for around 40% of the total where 5 main serogroups ACWY and B are responsible for the majority ...

Industries: Drug and Medication | Countries: World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America

Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • April 2014
  • 116 pages

Includes 3 FREE quarterly updates BMI View: The challenges facing drugmakers in Greece in 2012 will be considerably tougher than those faced in 2011. With the introduction of new cost-containment legislation in March 2012, the Greek government can now exercise much greater control over its pharmaceutical ...

Industries: Drug and Medication | Countries: Greece

Dermatologicals in Greece

Dermatologicals in Greece

  • $ 898
  • Industry report
  • by Euromonitor International
  • April 2014
  • 32 pages

During 2013, demand for dermatologicals in Greece was adversely affected by the economic recession the shrinking disposable incomes which came with it. However, the overall decline recorded in the category was moderate as the category had already suffered strong value declines between 2009 and 2012 and ...

Industries: Drug and Medication | Countries: Greece

NRT Smoking Cessation Aids Market Analysis in Greece

NRT Smoking Cessation Aids Market Analysis in Greece

  • $ 898
  • Industry report
  • by Euromonitor International
  • April 2014
  • 26 pages

The failure of the smoking ban led the government to implement a new and stricter ban on September 2010. According to the new law, smoking is forbidden in all public premises, with no exceptions whatsoever. However, the prospects of the new measure are not promising this time either. From the very first ...

Industries: Drug and Medication | Countries: Greece

Analgesics Market Analysis in Greece

Analgesics Market Analysis in Greece

  • $ 898
  • Industry report
  • by Euromonitor International
  • April 2014
  • 27 pages

In effect, consumers had to pay for 100% of the product’s price, whereas before May 2010 they only had to pay for 25%, with the state reimbursing the rest. This had a negative impact on volume sales across the whole category of analgesics; within analgesics,... Euromonitor International's report offers ...

Industries: Drug and Medication | Countries: Greece

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Greece

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Greece

  • $ 898
  • Industry report
  • by Euromonitor International
  • April 2014
  • 35 pages

Cough, cold and allergy remedies saw value sales decline by 1%. One reason was the milder winter, which did not favour the outbreak of cold or flu incidents. Furthermore, the waiting for the new, reduced price list caused many pharmacists to destock, often creating shortages in the industry . Finally, ...

Industries: Drug and Medication | Countries: Greece

Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2014
  • 117 pages

BMI View: It is beyond doubt that drugmakers in Greece – particularly domestic producers primarily exposed to their home industry – are faced with the most challenging operating environment in Europe. Our view that Greece’s pharmaceutical industry is set for a decade of decline remains firmly in ...

Industries: Drug and Medication | Countries: Greece

Greece Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2013
  • 113 pages

BMI View: It is now beyond doubt that drugmakers – particularly domestic producers, primarily exposed to their home industry – are faced with the most challenging operating environment in Europe. Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. ...

Industries: Drug and Medication | Countries: Greece

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.